Table 1.
Patient characteristics in the study
Items | |
---|---|
Age, mean±SD | 57.8±13.6 |
Histological grade, n (%) | |
I | 14 (11.3) |
II | 82 (66.1) |
III | 28 (22.6) |
ER expression, n (%) | |
Negative | 33 (26.2) |
Positive | 93 (73.8) |
PR expression, n (%) | |
Negative | 44 (34.9) |
Positive | 82 (65.1) |
HER2 amplification, n (%) | |
Negative | 64 (74.4) |
Positive | 22 (25.6) |
Molecular subtype, n (%) | |
Luminal A | 65 (54.2) |
Luminal B | 34 (28.3) |
HER2 overexpression | 10 (8.3) |
TNBC | 11 (9.2) |
Abbreviation: TNBC, triple-negative breast cancer.